Metabolomics Investigation Reveals Metabolite Mediators Associated with Acute Lung Injury and Repair in a Murine Model of Influenza Pneumonia
Name
Tannenbaum_Metabolomics Investigation.pdf
Size
3.45 MB
Format
Adobe PDF
Checksum (MD5)
6b0e2bc0df6a7fd04ac5c93316b47249
Author(s)
Cui, Liang
Zheng, Dahai
Lee, Yie Hou
Chan, Tze Khee
Kumar, Yadunanda
Ho, Wanxing Eugene
Ong, Choon Nam
Chen, Jianzhu
Tannenbaum, Steven R
Date Issued
May 2016
Journal
Scientific Reports
Publisher
Springer Nature
Citation
Cui, Liang, Dahai Zheng, Yie Hou Lee, Tze Khee Chan, Yadunanda Kumar, Wanxing Eugene Ho, Jian Zhu Chen, Steven R. Tannenbaum, and Choon Nam Ong. “Metabolomics Investigation Reveals Metabolite Mediators Associated with Acute Lung Injury and Repair in a Murine Model of Influenza Pneumonia.” Scientific Reports 6 (May 18, 2016): 26076.
Version
Final published version
Abstract
Influenza virus infection (IVI) can cause primary viral pneumonia, which may progress to acute lung injury (ALI) and respiratory failure with a potentially fatal outcome. At present, the interactions between host and influenza virus at molecular levels and the underlying mechanisms that give rise to IVI-induced ALI are poorly understood. We conducted a comprehensive mass spectrometry-based metabolic profiling of serum, lung tissue and bronchoalveolar lavage fluid (BALF) from a non-lethal mouse model with influenza A virus at 0, 6, 10, 14, 21 and 28 days post infection (dpi), representing the major stages of IVI. Distinct metabolite signatures were observed in mice sera, lung tissues and BALF, indicating the molecular differences between systematic and localized host responses to IVI. More than 100 differential metabolites were captured in mice sera, lung tissues and BALF, including purines, pyrimidines, acylcarnitines, fatty acids, amino acids, glucocorticoids, sphingolipids, phospholipids, etc. Many of these metabolites belonged to pulmonary surfactants, indicating IVI-induced aberrations of the pulmonary surfactant system might play an important role in the etiology of respiratory failure and repair. Our findings revealed dynamic host responses to IVI and various metabolic pathways linked to disease progression, and provided mechanistic insights into IVI-induced ALI and repair process.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Chemistry
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution 4.0 International License
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1038/srep26076
